FDA Approves Avandamet® (rosiglitazone Maleate And Metformin HCl) As Inital Therapy In The Treatment Of Type 2 Diabetes

... GlaxoSmithKline announced today FDA approval of Avandamet ® (rosiglitazone maleate and metformin HCl) for use as initial treatment of type 2 diabetes as an adjunct to diet and exercise. Avandamet was previously approved as a second-line therapy - it was indicated for use in patients who were uncontrolled on metformin monotherapy. [click link for full article] ...